Molecular Pathology of Lung Cancer
Surgical Pathology Clinics · 2026-06 · 19 (2) · 275-284
DOI: 10.1016/j.path.2026.01.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Surgical Pathology Clinics, 2026-06. Verfasst von Andrew Lingard und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada. Electronic address: alingard@uottawa.ca. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Biomarkers, Tumor, Pathology, Molecular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada. Electronic address: alingard@uottawa.ca.
- Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
Zitieren
APA
Lingard, A., & Dacic, S. (2026). Molecular Pathology of Lung Cancer. Surgical Pathology Clinics, 19(2), 275-284. https://doi.org/10.1016/j.path.2026.01.003
Vancouver
Lingard A, Dacic S. Molecular Pathology of Lung Cancer. Surgical Pathology Clinics. 2026;19(2):275-284. doi:10.1016/j.path.2026.01.003
BibTeX
@article{Lingard2026,
author = {Lingard, Andrew and Dacic, Sanja},
title = {Molecular Pathology of Lung Cancer},
journal = {Surgical Pathology Clinics},
year = {2026},
volume = {19},
number = {2},
pages = {275--284},
doi = {10.1016/j.path.2026.01.003}
}
EUVIMED